STIM Neuronetics, Inc.
$2.15
Neuronetics, Inc. (STIM) is expected to report earnings on February 3, 2027, before the market open. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -22.4% since its last earnings release on November 4, 2026.
Neuronetics Beat Consensus Estimates, Reaffirms Revenue Guidance
Wednesday, November 4, 2026 · 7:50 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 7:50 AM ET
Earnings Whisper
-
vs ($0.08)
Rev est $44.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$2.47
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Neuronetics, Inc.
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.